Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Finished Goods Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Sonoma Pharmaceuticals (SNOA) Current Taxes (2016 - 2017)

Sonoma Pharmaceuticals has reported Current Taxes over the past 2 years, most recently at $13000.0 for Q1 2017.

For Q1 2017, Current Taxes changed N/A year-over-year to $13000.0; the TTM value through Mar 2017 reached $13000.0, changed N/A, while the annual FY2017 figure was $13000.0, N/A changed from the prior year.
Current Taxes for Q1 2017 was $13000.0 at Sonoma Pharmaceuticals, down from $229000.0 in the prior quarter.
Over five years, Current Taxes peaked at $229000.0 in Q4 2016 and troughed at $13000.0 in Q1 2017.